Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
US7582638B2 · kind B2 · utility
11Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2006 |
| Grant date | Sep 1, 2009 |
| Priority date | — |
| Expiry date | Oct 23, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.